Jonathan Kantor

Dr. Jonathan Kantor is an Adjunct Assistant Professor of Dermatology at the Perelman School of Medicine, University of Pennsylvania. He is based in both the United Kingdom and the United States and is a leading figure in global dermatology, telemedicine, and AI-driven medical education. His work emphasizes equitable access to skin and cancer care through technological innovation and international collaboration.

His research interests span a broad and impactful range, including telemedicine, artificial intelligence in dermatology, global health education, digital pathology, and surgical outcome measurement. He has developed validated tools such as the SCAR scale for scar assessment and the Oxford Pandemic Attitude Scale, demonstrating his expertise in psychometric instrument development. His focus on low-cost, high-technology solutions enables scalable implementation in resource-limited settings.

The recent publications reflect a strong trend toward digital health innovation, global health equity, and pandemic response. His work integrates clinical dermatology with public health, technology, and education, often leveraging international datasets and collaborations. Themes include the use of 3D imaging, wireless transmission in pathology, AI applications, and scalable educational models.

Scientific Contributions:

• Editor-in-Chief, Journal of the American Academy of Dermatology International
• Author of over 100 peer-reviewed manuscripts, book chapters, and abstracts
• Author/editor of four textbooks published by McGraw-Hill
• Founding editor of a major dermatology journal

Dr. Kantor is deeply engaged in global health mentorship and education, particularly through the University of Pennsylvania’s Center for Global Health. He advises on international trainee programs and promotes year-out global health experiences. Though specific grant details are not listed, his projects suggest support for digital health innovation, telemedicine infrastructure, and global scale validation studies. His international research spans the UK, USA, and multiple low-resource regions.

He leads initiatives in digital dermatology innovation, including telemedicine platforms, 3D imaging systems, and AI-integrated diagnostic tools. His team focuses on developing feasible, valid, and reliable methods for global application, such as multilingual translation and validation of clinical scales. These efforts are coordinated through academic and global health networks, emphasizing cross-border collaboration.